News

AliveDx is dedicated to expanding its reach and presence across diverse regions, with the goal of delivering both clinical and economical value to clinicians by reducing the time to diagnosis for patients suffering from autoimmune and allergy diseases.  We are

We are delighted to speak at the upcoming International Friday Meeting on Friday, 6 December 2024 at 6:30AM CET. The International Friday Meeting is a monthly meeting, held on the first Friday of the month, hosted by Pr. Yehuda Shoenfeld.

AliveDx Suisse S.A. and Medikonia Limited have signed a distribution agreement, which will enable Medikonia to distribute the MosaiQ® solution in Hong Kong and Macau. The distribution agreement takes effect immediately. AliveDx is committed to broadening its reach and presence

We are proud to announce that we have become a member of BIVDA, the UK’s leading IVD industry association. BIVDA is the national industry association for manufacturers and distributors of medical diagnostic tests in the UK, representing 97% of the

AliveDx Suisse S.A. and Bio-State Inc. have signed a distribution agreement, which will enable Bio-State Inc. to distribute the MosaiQ® solution in India. The distribution agreement takes effect immediately. This strategic partnership with an important partner in India reaffirms AliveDx’s

Meet the Alba team at the AABB Annual Meeting to learn how our high-quality blood bank reagents can drive value in your lab! Sign up for a booth meeting with your Account Executive today.

Maximizing your valuable time and resources is essential for efficient laboratory operations. Experience firsthand the transformative capabilities of MosaiQ and LumiQ (IFA). Both solutions are designed to deliver actionable diagnostic insights more quickly and cost-effectively, helping you achieve more with

We are proud to announce that our manufacturing facility in Edinburgh, Scotland has been awarded the ISO 22301:2019 Security and resilience certificate. “Gaining the ISO 22301 standard for the UK site underlines AliveDx’s commitment to the needs of our customers.

We are proud to announce that our manufacturing facility in Eysins, Switzerland has been granted ISO 13485:2016 and Medical Device Single Audit Program (MDSAP) certifications for the design, development, production, and distribution of in-vitro diagnostic test kits and reagents for

At AliveDx, our mission is to empower diagnostic insights, transform patient care, and innovate for life. We are excited and proud to announce AliveDx has received IVDR-CE mark certification for its multiplexed MosaiQ AiPlex™ CD microarray immunoassay, designed to improve